Literature DB >> 18547100

Coordination of thrombolytic Pro-Ala-Lys peptides with Cu (II): leading to nanoscale self-assembly, increase of thrombolytic activity and additional vasodilation.

Xue Ren1, Guohui Cui, Ming Zhao, Chao Wang, Shiqi Peng.   

Abstract

Vasodilation is one of the biologically important properties for thrombolytic agents because of it may help thrombolysis via dilating blood vessels. Aimed at discovering agents with the dual-action of vasodilative and thrombolytic activities, H-Pro-Ala-Lys (PAK, 3a) and five novel analogs H-Pro-Ala-AA ( 2b-f, AA = Val, Phe, Ser, Glu, and His) were coordinated with Cu(II) to form Cu(II)-Pro-Ala-AA [( 3a-f) -Cu(II)]. The coordination chemistry was confirmed by the d-d transition occurred in their UV and circular dichroism (CD) spectra and the molecular ion in their electrospray ionization mass spectrometry (ESI-MS) spectra. The particle size tests of their solution and powders revealed that the coordination generally resulted in nanoscale self-assembly. Zeta potential and half-peak width tests indicated that the formed nanoparticles were sufficiently stable during the monitored 8 days. The bioassays implied that comparing to the PAK peptides themselves and CuCl 2 the coordination led to a 3000-fold increase of the in vitro thrombolytic activity, a 10-fold increase of the in vivo thrombolytic activity, and especially an additional vasodilation. Thus Cu(II)-peptide coordination indeed is a way for thrombolytic peptide design.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547100     DOI: 10.1021/jp800645g

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  4 in total

1.  Folded Conformation, Cyclic Pentamer, Nano-Structure and PAD4 Binding Mode of YW3-56.

Authors:  Haimei Zhu; Yuji Wang; Yaonan Wang; Shurui Zhao; Ming Zhao; Lin Gui; Wenyun Xu; Xiangyun Amy Chen; Yanming Wang; Shiqi Peng
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2013-05-16       Impact factor: 4.126

Review 2.  Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements.

Authors:  K K Pulicherla; Mahendra Kumar Verma
Journal:  AAPS PharmSciTech       Date:  2015-01-23       Impact factor: 3.246

Review 3.  Development of copper based drugs, radiopharmaceuticals and medical materials.

Authors:  Paweł Szymański; Tomasz Frączek; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Biometals       Date:  2012-08-23       Impact factor: 2.949

4.  Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.

Authors:  Shan Li; Yuji Wang; Feng Wang; Yaonan Wang; Xiaoyi Zhang; Ming Zhao; Qiqi Feng; Jianhui Wu; Shurui Zhao; Wei Wu; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2015-08-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.